BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 33295724)

  • 1. A new predictor to determine the exacerbation and treatment of chronic obstructive pulmonary disease: eosinophil/neutrophil ratio.
    Yakar Hİ; Kanbay A
    Tuberk Toraks; 2020 Sep; 68(3):260-267. PubMed ID: 33295724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eosinophilic and non-eosinophilic COPD patients with chronic respiratory failure: neutrophil-to-lymphocyte ratio as an exacerbation marker.
    Acartürk Tunçay E; Karakurt Z; Aksoy E; Saltürk C; Gungor S; Ciftaslan N; Irmak İ; Yavuz D; Ocakli B; Adıgüzel N
    Int J Chron Obstruct Pulmon Dis; 2017; 12():3361-3370. PubMed ID: 29200843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The utility of inflammatory markers to predict readmissions and mortality in COPD cases with or without eosinophilia.
    Duman D; Aksoy E; Agca MC; Kocak ND; Ozmen I; Akturk UA; Gungor S; Tepetam FM; Eroglu SA; Oztas S; Karakurt Z
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2469-78. PubMed ID: 26648709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association between eosinophilic exacerbation and eosinophilic levels in stable COPD.
    Kang HS; Kim SK; Kim YH; Kim JW; Lee SH; Yoon HK; Rhee CK
    BMC Pulm Med; 2021 Mar; 21(1):74. PubMed ID: 33653314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Upon-Diagnosis Blood Eosinophilic Count with Frequency and Severity of Annual Exacerbation in Chronic Obstructive Pulmonary Disease: A Prospective Longitudinal Analysis.
    Kiani A; Rahimi F; Afaghi S; Paat M; Varharam M; Dizaji MK; Dastoorpoor M; Abedini A
    Can Respir J; 2023; 2023():8678702. PubMed ID: 37153722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood cell for the differentiation of airway inflammatory phenotypes in COPD exacerbations.
    Gao J; Chen B; Wu S; Wu F
    BMC Pulm Med; 2020 Feb; 20(1):50. PubMed ID: 32093672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does eosinophilia and neutrophil to lymphocyte ratio affect hospital re-admission in cases of COPD exacerbation?
    Çoban Ağca M; Aksoy E; Duman D; Özmen İ; Yıldırım E; Güngör S; Durmuş N; Aka Aktürk Ü; Saltürk C; Tepetam FM; Karakurt Z
    Tuberk Toraks; 2017 Dec; 65(4):282-290. PubMed ID: 29631526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppressor of variegation 3-9 homologue 1 impairment and neutrophil-skewed systemic inflammation are associated with comorbidities in COPD.
    Chen TT; Wu SM; Chen KY; Tseng CH; Ho SC; Chuang HC; Feng PH; Liu WT; Han CL; Huang EW; Yeh YK; Lee KY
    BMC Pulm Med; 2021 Oct; 21(1):276. PubMed ID: 34598691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood eosinophils as a biomarker of future COPD exacerbation risk: pooled data from 11 clinical trials.
    Singh D; Wedzicha JA; Siddiqui S; de la Hoz A; Xue W; Magnussen H; Miravitlles M; Chalmers JD; Calverley PMA
    Respir Res; 2020 Sep; 21(1):240. PubMed ID: 32943047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the clinical characteristics and treatment outcomes of patients requiring hospital admission to treat eosinophilic and neutrophilic exacerbations of COPD.
    Kang HS; Rhee CK; Kim SK; Kim JW; Lee SH; Yoon HK; Ahn JH; Kim YH
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2467-2473. PubMed ID: 27757029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sputum inflammation predicts exacerbations after cessation of inhaled corticosteroids in COPD.
    Liesker JJ; Bathoorn E; Postma DS; Vonk JM; Timens W; Kerstjens HA
    Respir Med; 2011 Dec; 105(12):1853-60. PubMed ID: 21802933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood Eosinophils and Outcomes in Severe Hospitalized Exacerbations of COPD.
    Bafadhel M; Greening NJ; Harvey-Dunstan TC; Williams JE; Morgan MD; Brightling CE; Hussain SF; Pavord ID; Singh SJ; Steiner MC
    Chest; 2016 Aug; 150(2):320-8. PubMed ID: 26851799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term oxygen treatment need is less frequent in eosinophilic COPD patients.
    Acet-Öztürk NA; Dilektasli AG; Aydın-Güçlü Ö; Demirdöğen E; Coşkun F; Ursavaş A; Karadağ M; Uzaslan E
    Clin Respir J; 2022 Jan; 16(1):49-56. PubMed ID: 34626077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benralizumab for chronic obstructive pulmonary disease and sputum eosinophilia: a randomised, double-blind, placebo-controlled, phase 2a study.
    Brightling CE; Bleecker ER; Panettieri RA; Bafadhel M; She D; Ward CK; Xu X; Birrell C; van der Merwe R
    Lancet Respir Med; 2014 Nov; 2(11):891-901. PubMed ID: 25208464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction value of neutrophil and eosinophil count at risk of COPD exacerbation.
    Chen TT; Lee KY; Chang JH; Chung CL; Tran HM; Manullang A; Ho SC; Chen KY; Tseng CH; Wu SM; Chuang HC
    Ann Med; 2023; 55(2):2285924. PubMed ID: 38065676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations of the neutrophil-lymphocyte ratio during the period of stable and acute exacerbation of chronic obstructive pulmonary disease patients.
    Taylan M; Demir M; Kaya H; Selimoglu Sen H; Abakay O; Carkanat Aİ; Abakay A; Tanrikulu AC; Sezgi C
    Clin Respir J; 2017 May; 11(3):311-317. PubMed ID: 26096858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood Eosinophilia and Its Stability in Hospitalized COPD Exacerbations are Associated with Lower Risk of All-Cause Mortality.
    Zhang Y; Liang LR; Zhang S; Lu Y; Chen YY; Shi HZ; Lin YX
    Int J Chron Obstruct Pulmon Dis; 2020; 15():1123-1134. PubMed ID: 32547000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eosinophilic and Neutrophilic Airway Inflammation in the Phenotyping of Mild-to-Moderate Asthma and Chronic Obstructive Pulmonary Disease.
    Górska K; Paplińska-Goryca M; Nejman-Gryz P; Goryca K; Krenke R
    COPD; 2017 Apr; 14(2):181-189. PubMed ID: 27983888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The neutrophil/lymphocyte ratio is a better addition to C-reactive protein than CD64 index as a marker for infection in COPD.
    Farah R; Ibrahim R; Nassar M; Najib D; Zivony Y; Eshel E
    Panminerva Med; 2017 Sep; 59(3):203-209. PubMed ID: 28185443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral blood eosinophils: a surrogate marker for airway eosinophilia in stable COPD.
    Negewo NA; McDonald VM; Baines KJ; Wark PA; Simpson JL; Jones PW; Gibson PG
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1495-504. PubMed ID: 27445469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.